OnKure Therapeutics, Inc. fell 12.6% on Friday, November 13, 2026, on 891,350 shares, 2.8 times its average daily volume. No headline about OKUR came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
OnKure Therapeutics, Inc. (OKUR:NASDAQ) closed at $2.63 on November 13, 2026, down 12.62% on the day. The stock trades 51.1% below its 52-week high of $5.38 and 30.8% above its 52-week low of $2.01. Over the past year, it lost 16.8%. OnKure Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, OKUR closed higher on 108 days (43%). Its best day was December 5, 2025 (+16.35%) and its worst was March 27, 2026 (-13.07%). The stock moved 10% or more in a single session 13 times. It opened at least 5% above the previous day's high 1 time.
Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.
Find more stocks like OKUR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.